
Overview
Walmark makes dietary supplements with vitamins, minerals and herbal extracts, plus products for kids, female health, male health, joint health, gut health and respiratory health. It operates across Central and Eastern Europe, is headquartered in the Czech Republic, and sells in more than 40 countries. Its portfolio includes over 650 products.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $1,637,248 | |
| Profit allocation | Covers prior losses | |
| Loans and borrowings | $39,176,293 | |
| Foreign sales | 0.21% of revenue ($206,031) | |
| Revenue structure | Sprzedaż produktów/usług | |
| Related parties | 5 items |
Filing timeliness
1 of 6 financial statements was filed late (for 2020, 70 days late). All were audited by a statutory auditor.
- 202520/05/2026
- 202416/06/2025
- 202315/04/2024
- 202231/05/2023
- 202107/06/2022
- 202024/05/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Vitamin supplements
- Mineral supplements
- Herbal supplements
- Children's supplements
- Women's supplements
- Joint health supplements
Websites
The company has 8 websites. Most of them run on WordPress. The sites are available in: Polish, English and German. The sites target these markets: Germany and United Kingdom.
- arthroncomplex.plStrona główna – Arthron ComplexWordPress 7.1Google Tag ManagerYoast SEOApache
- itami.plITAMI – plastry przeciwbólowe z diklofenakiemWordPress 7.1ElementorGoogle Tag ManagerYoast SEOLLiteSpeed
- nizoral.plSzampon przeciwłupieżowy Nizoral - leczy przyczynę łupieżu ✅ | NizoralGoogle Tag ManagerCloudflare
Job offers
The company has its own careers page: jobs.stada.com.
Authorized Representatives
Manner of representation
If the management board is a one-person management board, a member of the management board acting independently is authorized to represent the company. If the management board is a multi-member management board, two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stada Arzneimittel Ag | 311 | $285,629.39 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Capital group
The company belongs to the Nidda German Topco GmbH (Germany) group, which is its direct owner. The group has 17 companies, 15 of them abroad.
| Name | Country |
|---|---|
| BEPHA Beteiligungsgesellschaft für Pharmawerte mbH | |
| BIOCEUTICALS Arzneimittel Aktiengesellschaft | |
| Britannia Pharmaceuticals Limited | |
| EG | |
| Hemopharm GmbH |
Bank accounts
Registered as a VAT taxpayer on 2003-10-01.
15 1030 1508 0000 0005 0190 9033
59 1030 1508 0000 0005 0190 9114
81 1030 1508 0000 0005 0190 9009
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 12, 2024 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Olimp Laboratories sp. z o.o. | $123,984,672.64 | olimp-labs.pl | ||
| Oleofarm sp. z o.o. | $68,110,367.86 | oleofarm.pl | ||
| Unipro sp. z o.o. | $62,412,723.24 | activlab.pl | ||
| KFD sp. z o.o. | $58,961,150.01 | kfd.pl | ||
| Medicaline sp. z o.o. | $46,877,712.69 | medicaline.pl | ||
| Orkla Care S.A. | $43,777,691.06 | orklacare.com.pl | ||
| Ekamedica sp. z o.o. + limited partnership | $18,889,143.89 | ekamedica.pl | ||
| Nutropharma sp. z o.o. | $13,240,122.91 | nutropharma.pl | ||
| Aura Herbals sp. z o.o. | $11,101,586.81 | auraherbals.pl | ||
| Panawit sp. z o.o. | $10,791,432.08 | panawit.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-01-03 | Share capital increase (1,054,000.00 PLN → 1,057,400.00 PLN) | |
| 2021-03-26 | Address change (Teatralna 9, 41-200, Sosnowiec → Ul. Krakowiaków 44, 02-255, Warszawa) | |
| 2021-03-26 | Name change (Walmark → Stada Pharm) | |
| 2003-02-17 | Share capital increase (51,000.00 PLN → 1,054,000.00 PLN) | |
| 2001-11-29 | Entered in the register |
FAQ
Last updated: 2026-10-07